Preventing Cancer, Cardiovascular Disease, and Diabetes
A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association
- Harmon Eyre, MD, CHIEF MEDICAL OFFICER,
- Richard Kahn, PHD, CHIEF SCIENTIFIC AND MEDICAL OFFICER,
- Rose Marie Robertson, MD, FAHA, CHIEF SCIENCE OFFICER and
- on behalf of the ACS/ADA/AHA Collaborative Writing Committee*
Abstract
Collectively, cardiovascular disease (including stroke), cancer, and diabetes account for approximately two-thirds of all deaths in the U.S. and about $700 billion in direct and indirect economic costs each year. Current approaches to health promotion and prevention of cardiovascular disease, cancer, and diabetes do not approach the potential of the existing state of knowledge. A concerted effort to increase application of public health and clinical interventions of known efficacy to reduce prevalence of tobacco use, poor diet, and insufficient physical activity—the major risk factors for these diseases—and to increase utilization of screening tests for their early detection could substantially reduce the human and economic cost of these diseases. In this article, the American Cancer Society, American Diabetes Association, and American Heart Association review strategies for the prevention and early detection of cancer, cardiovascular disease, and diabetes, as the beginning of a new collaboration among the three organizations. The goal of this joint venture is to stimulate substantial improvements in primary prevention and early detection through collaboration between key organizations, greater public awareness about healthy lifestyles, legislative action that results in more funding for and access to primary prevention programs and research, and reconsideration of the concept of the periodic medical checkup as an effective platform for prevention, early detection, and treatment.
- ACS, American Cancer Society
- ADA, American Diabetes Association
- AHA, American Heart Association
- CDC, Centers for Disease Control and Prevention
- FPG, fasting plasma glucose
- HPV, human papilloma virus
- IFG, impaired fasting glucose
- IGT, impaired glucose tolerance
- OGTT, oral glucose tolerance test
Footnotes
-
*Members of the the ACS/ADA/AHA Collaborative Writing Committee are listed in the appendix.
In these discussions, cardiovascular disease includes diseases of the heart, hypertension, stroke, and peripheral vascular diseases.
Simultaneous publication: This article is being simultaneously published in 2004 in CA: A Cancer Journal for Clinicians, Diabetes Care, Circulation, and Stroke by The American Cancer Society, the American Diabetes Association, and the American Heart Association.
- DIABETES CARE














